Stempoint Capital »

Proqr Thrapeutics N V shs euro shares owned by Stempoint Capital

Quarter-by-quarter ownership of Proqr Thrapeutics N V shs euro (PRQR) shares owned by Stempoint Capital from 13F filings

Historical chart of Stempoint Capital investment in Proqr Thrapeutics N V shs euro

Tip: Access up to 7 years of quarterly data

All positions including Proqr Thrapeutics N V shs euro held by Stempoint Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Proqr Thrapeutics N V shs euro by Stempoint Capital

Quarter filed Position value Share count Share price at filing
2026-06-30 $802k 431k 1.86

More positions owned by Stempoint Capital

Tango Therapeutics (TNGX)
Abivax Sa Sponsored Ads (ABVX)
Revolution Medicines (RVMD)
Erasca (ERAS)
Biohaven (BHVN)
Tyra Biosciences (TYRA)
Dianthus Therapeutics (DNTH)
Enliven Therapeutics (ELVN)
Mineralys Therapeutics (MLYS)
Roivant Sciences SHS (ROIV)
Surrozen Com New (SRZN)
Kiniksa Pharmaceuticals Intl Ord Shs Cl A (KNSA)
Scholar Rock Hldg Corp (SRRK)
Alkermes SHS (ALKS)
First Tracks Biotherapeutics Ord Shs (TRAX)

View all positions for Stempoint Capital

Top funds holding Proqr Thrapeutics N V shs euro

Adage Capital Partners GP
Standard Life Aberdeen
Affinity Asset Advisors
Privium Fund Management B.V.
Ikarian Capital
Woodline Partners
Heights Capital Management
Sphera Funds Management
Kynam Capital Management
DAFNA Capital Management
Squadron Capital Management
683 Capital Management
Morgan Stanley
Citadel Advisors
Platinum Investment Mangement

View all funds holding Proqr Thrapeutics N V shs euro